RecruitingNCT03436069

Identification of New Prognostic Markers for Breast Cancer.

Identification de Nouveaux Marqueurs Pronostiques Des Cancers du Sein


Sponsor

University Hospital, Grenoble

Enrollment

1,500 participants

Start Date

Jan 1, 2011

Study Type

OBSERVATIONAL

Conditions

Summary

Candidate markers have been identified thanks to an original approach developed by our research team aiming at detecting ectopic gene expression using public pan-genomic breast cancer data. The same approach had already been used and validated in lung tumors, leukemias and lymphomas. The main objective of the present research is to use tumor samples from patients in a retrospective and prospective cohort to test and validate the relevance of these prognostic markers in breast cancer.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria1

  • Adult female patients with breast cancer

Exclusion Criteria4

  • Presence of another cancer, excluding basal cell cancers or pre-neoplastic lesions of the cervix.
  • Subject under guardianship or subject deprived of liberty
  • Impossibility of collecting information on exposure (subjects recently arrived in France, foreign language, etc.)
  • Male patients

Interventions

OTHERConventional treatment protocols of breast cancer

Locations(1)

Anne-Cécile PHILIPPE

Grenoble, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03436069


Related Trials